ProCE Banner Activity

Experts Address HCP Questions on Contemporary Treatment for CLL

Clinical Thought

In this commentary, expert faculty address questions from a live audience at ASH 2022 on current and emerging management strategies for patients with chronic lymphocytic leukemia.

Released: January 30, 2023

Expiration: January 29, 2024

No longer available for credit.



Deborah Stephens

Deborah Stephens, DO

Associate Professor
Director of the CLL Program
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, North Carolina

Jennifer Woyach

Jennifer Woyach, MD

D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Leader Leukemia Research Program
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

ProCE Banner





Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc